Home›Companies›Healthcare›NovaScan

Novascan Inc.

NovaScan develops cancer detection devices to help surgeons assess tissue during surgery.

Updated Nov 9, 2026·Latest SEC filing Aug 18, 2026·Suggest an edit

About NovaScan

NovaScan is a private company based in Milwaukee, Wisconsin. It has reported $3,234,179 raised in five offerings on Form D since July 2017. Its chief executive is Craig Davis.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 28, 2026May 22, 2026amended Aug 18, 2026$3,084,179of $3.5M target34$90,711Convertible DebtRule 506(b)Form D/A ↗1 earlier filing
Not yetNov 29, 2022$0of $3.0M target0—Equity, Convertible debtRule 506(b)Form D ↗
Not yetOct 25, 2021$0of $8.0M target0—EquityRule 506(b)Form D ↗
Sep 2, 2020Oct 28, 2020$100,000of $1.0M target4$25,000Convertible debtRule 506(b)Form D ↗
Jul 10, 2017Jul 24, 2017$50,000of $2.0M target1$50,000EquityRule 506(b)Form D ↗
Total, five offerings$3,234,179

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on NovaScan's Form D filed Aug 18, 2026.

RZ
AM
Amit Mehta
Executive officer and director
CD
Craig Davis
CEO and director

Earlier filings also listed Charles Link (director, last listed Nov 2022), C. Richard Plazza (director, last listed Nov 2022), William Gregory (executive officer and director, last listed Oct 2021), William Wangerin (director, last listed Jul 2017), Tsuri Bernstein (executive officer and director, last listed Jul 2017) and Joel Weinstein (director, last listed Jul 2017).

Sources

  1. SECNovascan Inc. Form D, filed May 22, 2026
  2. SECNovascan Inc. filing history
  3. PressNovaScan CPRIT grant announcement